KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) Revenue History
Annual and quarterly revenue from 2020 to present
KMTS Revenue Over Time (2020–2025)
KMTS Revenue Growth History
2 of 2 years with positive growth- FY2020 revenue growth
- N/A
- FY2021 revenue growth
- N/A
- FY2023 revenue growth
- N/A
- FY2024 revenue growth
- +264.5%
- FY2025 revenue growth
- +115.1%
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.6M | +62.7% |
| Q2 2026 | $22.6M | +53.4% |
| Q1 2026 | $19.4M | — |
| Q4 2025 | $17.2M | +71.4% |
| Q3 2025 | $15.1M | — |
| Q2 2025 | $14.7M | — |
| Q4 2024 | $10.1M | — |
| Q1 2022 | $0 | — |
KMTS Revenue Analysis (2020–2025)
Current Revenue & Growth
As of June 22, 2026, KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) generated trailing twelve-month (TTM) revenue of $83.7 million, reflecting explosive growth of +62.7% year-over-year. The most recent quarter (Q3 2026) recorded $24.6 million in revenue, up 8.8% sequentially.
Historical Growth Trajectory
KMTS's historical revenue data shows various trends over time. KESTRA MEDICAL TECHNOLOGIES, LTD.'s highest annual revenue of $59.8 million was recorded in 2025, an all-time high.
Peer Comparison
Compared to Healthcare sector peers — including MDT (+6.9% YoY), ABT (+6.4% YoY), and BSX (+19.9% YoY) — KMTS has outperformed the peer group in revenue growth. Compare KMTS vs MDT →
KMTS Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| KMTSCurrent | $84M | +62.7% | - | -177.8% | |
 MDT | $33.5B | +6.9% | +3.0% | 17.8% | |
 ABT | $42.0B | +6.4% | +5.6% | 16.3% | |
 BSX | $20.1B | +19.9% | +15.2% | 19.8% | |
 EW | $6.1B | +11.2% | +6.7% | 27.0% | |
 LIVN | $1.4B | +12.4% | +8.2% | 14.4% |
KMTS Historical Revenue Data (2020–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $59.8M | +115.1% | $24.2M | 40.5% | $-106,378,000 | -177.8% |
| 2024 | $27.8M | +264.5% | $362K | 1.3% | $-85,063,000 | -305.8% |
| 2023 | $7.6M | - | $-10,651,000 | -139.6% | $-80,421,000 | -1054.0% |
| 2021 | $0 | - | $0 | - | $-32,708,000 | - |
| 2020 | $0 | - | $0 | - | $-29,319,000 | - |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
6+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
KMTS — Frequently Asked Questions
Quick answers to the most common questions about buying KMTS stock.
Is KMTS's revenue growth accelerating or slowing?
KMTS revenue growth is accelerating. TTM revenue reached $84M, up +62.7% year-over-year — ahead of the 5-year CAGR of N/A. This indicates the business is expanding faster than its historical baseline.
What is KMTS's revenue history from 2020 to 2026?
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) revenue history spans 2020 to 2026. TTM revenue as of 2026 is $84M, growing at +62.7% YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is KMTS's long-term revenue growth rate (CAGR)?
KESTRA MEDICAL TECHNOLOGIES, LTD.'s 5-year revenue CAGR of N/A reflects the sustained nature of its business expansion. As of 2026, the current YoY growth rate of +62.7% is above this long-term average. CAGR is the most reliable measure of sustained revenue momentum for KMTS.
Why does KMTS's quarterly revenue fluctuate?
KMTS quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. KESTRA MEDICAL TECHNOLOGIES, LTD.'s revenue data from 2020 to 2026 shows full historical quarterly detail on this page.
How is KMTS's revenue distributed by segment?
KMTS reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does KMTS's revenue compare to industry peers?
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) with TTM revenue of $84M and +62.7% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.